Overview

G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome

Status:
Terminated

Trial end date:
2015-01-01

Target enrollment:

Participant gender:

Summary

The purposes of this study are: - To examine the engraftment rate in patients receiving in vivo T-cell-depleted G-CSF stimulated bone marrow from partially mismatched related donors. - To evaluate the incidence and severity of acute and chronic graft-versus-host disease in patients receiving in vivo T-cell-depleted G-CSF stimulated bone marrow from partially mismatched related donors.

Phase:

N/A

Details

Lead Sponsor:

Emory University

Treatments:

Lenograstim
Sargramostim